Spyre Therapeutics, Inc.SYRENASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 19 | 2↓87.6% | 1↓62.0% | 0 |
| Gross Profit | -2 | 19↑1253.9% | 2↓87.6% | 1↓62.0% | 0 |
| Operating Income | -81 | -66↑19.4% | -85↓29.1% | -242↓185.8% | -209↑13.9% |
| Net Income | -81 | -66↑18.7% | -84↓27.4% | -339↓304.2% | -208↑38.6% |
| EBITDA | -79 | -64↑19.2% | -83↓29.3% | -128↓54.1% | -208↓63.0% |
| EPS Diluted | -37.89 | -25.02↑34.0% | -24.86↑0.6% | -46.15↓85.6% | -3.18↑93.1% |